Annual SG&A
$13.01 M
+$2.85 M+28.02%
31 December 2023
Summary:
Longboard Pharmaceuticals annual selling, general & administrative expenses is currently $13.01 million, with the most recent change of +$2.85 million (+28.02%) on 31 December 2023. During the last 3 years, it has risen by +$3.24 million (+33.17%). LBPH annual SG&A is now at all-time high.LBPH Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$6.67 M
+$1.48 M+28.40%
30 September 2024
Summary:
Longboard Pharmaceuticals quarterly selling, general & administrative expenses is currently $6.67 million, with the most recent change of +$1.48 million (+28.40%) on 30 September 2024. Over the past year, it has increased by +$3.58 million (+115.71%). LBPH quarterly SG&A is now -15.92% below its all-time high of $7.94 million, reached on 31 December 2020.LBPH Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$675.32 M
-$76.34 M-12.75%
30 September 2024
Summary:
Longboard Pharmaceuticals TTM selling, general & administrative expenses is currently -$675.32 million, with the most recent change of -$76.34 million (-12.75%) on 30 September 2024. Over the past year, it has dropped by -$687.49 million (-5650.91%). LBPH TTM SG&A is now -4589.75% below its all-time high of $20.19 million, reached on 30 September 2024.LBPH TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LBPH Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.0% | +115.7% | -5650.9% |
| 3 y3 years | +33.2% | +195.1% | -5074.0% |
| 5 y5 years | - | - | - |
LBPH Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +61.3% | at high | +195.1% | -610.9% | at low |
| 5 y | 5 years | at high | +61.3% | -15.9% | +5703.5% | -4589.8% | at low |
| alltime | all time | at high | +61.3% | -15.9% | +5703.5% | -4589.8% | at low |
Longboard Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.67 M(+28.4%) | $20.19 M(+21.6%) |
| June 2024 | - | $5.20 M(+5.2%) | $16.61 M(+14.4%) |
| Mar 2024 | - | $4.94 M(+46.4%) | $14.52 M(+11.6%) |
| Dec 2023 | $13.01 M(+28.0%) | $3.38 M(+9.1%) | $13.01 M(+6.9%) |
| Sept 2023 | - | $3.09 M(-0.4%) | $12.17 M(+5.3%) |
| June 2023 | - | $3.11 M(-9.5%) | $11.55 M(+4.1%) |
| Mar 2023 | - | $3.43 M(+35.4%) | $11.09 M(+9.2%) |
| Dec 2022 | $10.16 M | $2.53 M(+2.1%) | $10.16 M(+1.1%) |
| Sept 2022 | - | $2.48 M(-6.2%) | $10.05 M(+2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | $2.65 M(+5.9%) | $9.83 M(+6.2%) |
| Mar 2022 | - | $2.50 M(+3.0%) | $9.26 M(+14.8%) |
| Dec 2021 | $8.06 M(-17.4%) | $2.43 M(+7.3%) | $8.06 M(-40.6%) |
| Sept 2021 | - | $2.26 M(+9.2%) | $13.58 M(+10.7%) |
| June 2021 | - | $2.07 M(+58.8%) | $12.26 M(+11.9%) |
| Mar 2021 | - | $1.30 M(-83.6%) | $10.96 M(+12.2%) |
| Dec 2020 | $9.77 M | $7.94 M(+738.2%) | $9.77 M(+434.0%) |
| Sept 2020 | - | $947.00 K(+23.5%) | $1.83 M(+107.4%) |
| June 2020 | - | $767.00 K(+567.0%) | $882.00 K(+667.0%) |
| Mar 2020 | - | $115.00 K | $115.00 K |
FAQ
- What is Longboard Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Longboard Pharmaceuticals?
- What is Longboard Pharmaceuticals annual SG&A year-on-year change?
- What is Longboard Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Longboard Pharmaceuticals?
- What is Longboard Pharmaceuticals quarterly SG&A year-on-year change?
- What is Longboard Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Longboard Pharmaceuticals?
- What is Longboard Pharmaceuticals TTM SG&A year-on-year change?
What is Longboard Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of LBPH is $13.01 M
What is the all time high annual SG&A for Longboard Pharmaceuticals?
Longboard Pharmaceuticals all-time high annual selling, general & administrative expenses is $13.01 M
What is Longboard Pharmaceuticals annual SG&A year-on-year change?
Over the past year, LBPH annual selling, general & administrative expenses has changed by +$2.85 M (+28.02%)
What is Longboard Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of LBPH is $6.67 M
What is the all time high quarterly SG&A for Longboard Pharmaceuticals?
Longboard Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $7.94 M
What is Longboard Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, LBPH quarterly selling, general & administrative expenses has changed by +$3.58 M (+115.71%)
What is Longboard Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of LBPH is -$675.32 M
What is the all time high TTM SG&A for Longboard Pharmaceuticals?
Longboard Pharmaceuticals all-time high TTM selling, general & administrative expenses is $20.19 M
What is Longboard Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, LBPH TTM selling, general & administrative expenses has changed by -$687.49 M (-5650.91%)